




版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Dr.Feng肺動(dòng)脈漂浮導(dǎo)管PAC2020-12-081肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Dr.Feng肺動(dòng)脈漂浮導(dǎo)管PAC2020-12-081肺動(dòng)ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-082肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlaceWhatisPulmonaryArteryCatheter?Fullname:Swan-GanzCatheterUsedittomonitorapatient’shemodynamicswhenwecantanswerthequestionusingnoninvasive/clinicalmeasures
2020-12-083肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatisPulmonaryArteryClinicaluseofthePAC(Diagnosis)Differentiationamongcausesofshock
CardiogenicHypovolemicDistributive(sepsis)Obstructive(massivepulmonaryembolism)
DifferentiationofpulmonaryedemaCardiogenicNoncardiogenic
EvaluationofpulmonaryhypertensionDiagnosisofleft-to-rightintracardiacshuntDiagnosisofpericardialtamponade2020-12-084肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ClinicaluseofthePAC(DiagnClinicaluseofthePAC(Therapy)ManagementofperioperativepatientwithunstablecardiacstatusManagementofcomplicatedmyocardialinfarctionManagementofseverepreeclampsiaGuidetopharmacologictherapy
Vasopressors;Inotropes;VasodilatorsGuidetononpharmacologictherapy
Fluidmanagement;Burns;Renalfailure;Sepsis;Heartfailure;DecompensatedcirrhosisVentilatormanagement
AssessmentofbestPEEPforDO22020-12-085肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ClinicaluseofthePAC(TherapContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-086肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlaceStructureofPAC2020-12-087肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)StructureofPAC2020-12-087肺動(dòng)脈PAC2020-12-088肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC2020-12-088肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)首選:右頸內(nèi)靜脈2020-12-089肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)首選:右頸內(nèi)靜脈2020-12-089肺動(dòng)脈漂浮導(dǎo)管PAC(ComparisonamongPAcatheterinsertionsites2020-12-0810肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ComparisonamongPAcatheteriPACinsertionRightinternaljugularvein
ShortestandstraightestpathtotheheartLeftsubclavianDoesnotrequirethePACtopassandcourseatanacuteangletoentertheSVCFemoralveinsDistantsitesPassingaPACintotheheartcanbedifficultFluoroscopicassistancemaybenecessaryCompressibleandpreferableiftheriskofhemorrhageishigh2020-12-0811肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PACinsertionRightinternaljPACinsertionAfterinsertingthePACasfarasthe20cmmark,theballoonisinflatedwithair.Inflationshouldbeslowandcontrolled(1mL/s)andshouldnotsurpasstherecommendedvolume(1.5mL).AlwaysinflatetheballoonbeforeadvancingthePACandalwaysdeflatetheballoonbeforewithdrawingthePAC.
CRX:checkthepositionofthePACPAdiastolicpressure~PAWP2020-12-0812肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PACinsertionAfterinsertingtPAConCRX(PA)2020-12-0813肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAConCRX(PA)2020-12-0813肺動(dòng)脈漂Placementofthecatheter
2020-12-0814肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Placementofthecatheter
2020RightAtrium>>20cmNormalrightatrialpresssureis0-6cmHg.Normaloxygencontent15%(ml/dL)NormalO2saturation75%2020-12-0815肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RightAtrium>>20cm2020-12-081WaveformsofCVP
2020-12-0816肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WaveformsofCVP
2020-12-081EKG-RAPEKG
MechanicaleventRAP80–100millisecondsafterPwaveRAsystole
a
waveRAdiastolex
descentAfterQRSTricuspidvalveclosurecwaveAfterpeakofTwaveRAfilling/tricuspidvalveclosedv
waveRAemptyingatopeningoftricuspidvalve/onsetofrightventriclediastole
y
descent2020-12-0817肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)EKG-RAPEKGMechanicaleventRightAtrium2020-12-0818肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RightAtrium2020-12-0818肺動(dòng)脈漂浮導(dǎo)RightventricularwaveformRVsystolic=17-30cmHgRVdiastolic=0-6cmHgRVO2content=15%(ml/dL)RVO2saturation75%2020-12-0819肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RightventricularwaveforPulmonaryarterywaveform
NormalPApressure,systolic15-30NormalPApressure,diastolic5-13O2content15%(ml/dL)O2saturation75%2020-12-0820肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PulmonaryarterywaveforEKG-PAPEKGMechanicaleventPAPTwaveRightventricleejectionofbloodintopulmonaryvasculature
Systolic
PAS15–30mmHg80millisecondsafteronsetofQRS
IndirectindicatorofLVEDP
End-diastolic
(PAEDP8–12mmHg)Mean(9–18mmHg)PAS:pulmonaryarterysystolicLVEDP:leftventricularend-diastolicpressurePAEDP:pulmonaryarteryend-diastolicpressure2020-12-0821肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)EKG-PAPEKGMechanicaleventPulmonaryarterywaveform
2020-12-0822肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Pulmonaryarterywaveform
2020PAWPwaveform2020-12-0823肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPwaveform2020-12-0823肺動(dòng)脈PAWPwaveform2020-12-0824肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPwaveform2020-12-0824肺動(dòng)脈漂浮EKG-PAWPEKG
MechanicaleventPAWPAlignedwiththeendoftheQRS
Leftatrial(LA)systolea
waveLAdiastolex
descentT-PintervalLAfilling/mitralvalveclosedv
waveLAemptyingatopeningofmitralvalve/onsetofleftventriclediastoley
descent2020-12-0825肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)EKG-PAWPEKGMechanicaleventPAWPwaveform2020-12-0826肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPwaveform2020-12-0826肺動(dòng)脈漂浮ECG--CVP--PAWP2020-12-0827肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ECG--CVP--PAWP2020-12-0827HowdouknowurinZone3?CathetershouldbebelowtheleftatriumonCRXIfthereismarkedrespiratoryvairationinthePAWPtracingyouarelikelynotinZone3IfPAD>PAWPthenyouarelikelynotinZone32020-12-0828肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)HowdouknowurinZone3?CRapidFlushTest(方波試驗(yàn))2020-12-0829肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RapidFlushTest(方波試驗(yàn))2020-12-PhlebostaticAxis2020-12-0830肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PhlebostaticAxis2020-12-08PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-0831肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-0831肺PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-0832肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-0832肺ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
Parameterintegration2020-12-0833肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlaceHemodynamicvaluesofnormaladults2020-12-0834肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)HemodynamicvaluesofnormHemodynamicMonitoringCOCISVSVIRAP(CVP)PAPPAWPCardiacoutputPressureSvO22020-12-0835肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)HemodynamicMonitoringRAP(CVP)CardiacOutput(CO)定義:在1min內(nèi)從心室射出的血液總量公式:CO=HRxSVCO=4~8L/min2020-12-0836肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)CardiacOutput(CO)CardiacOutputIndex(CI)
CI=CO/BSA正常值:2.8–4.2L/min/m2CI更能體現(xiàn)患者的個(gè)體差異性2020-12-0837肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)CardiacOutputIndex(CI)CI每搏量(SV)
與每搏量指數(shù)(SVI)SV定義:每次心跳所射出的血液量SV=CO/HRSV正常值:50-110ml/beatSVI=SV/BSASVI正常值:30-65ml/m2/beat2020-12-0838肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)每搏量(SV)與每搏量指數(shù)(SVI)SV定義:每次心跳WhatElevatestheRightAtrialPressure?RVinfarctPulmonaryhypertensionPulmonarystenosisLefttorightshuntTricuspidvalvulardiseaseLeftheartfailure2020-12-0839肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatElevatestheRightAtrialProminentRApulsationsProminentawave:
TricuspidstenosisCannonawave:
AVdissociation
VentriculartachycardiaProminentvwave:
TricuspidregurgitationorVSD2020-12-0840肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ProminentRApulsationsPromineWhatIncreasesRVPressures?RVfailurePulmonaryhypertensionPulmonarystenosisPulmonaryEmbolismCardiomyopathyCardiactamponadeCardiacconstriction2020-12-0841肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatIncreasesRVPressures?RVWhatElevatesPApressure?VolumeOverload(backflow)PrimarylungdiseasePrimarypulmonaryhypertensionPulmonaryEmbolismLefttorightshuntMitralValveDisease2020-12-0842肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatElevatesPApressure?Volu用壓力推測(cè)心室舒張末期容量的前提
導(dǎo)管位置無(wú)二尖瓣心室順應(yīng)性正確疾病正常
PAWP~LAP~LVEDP~LVEDV~Preload2020-12-0843肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)用壓力推測(cè)心室舒張末期容量的前提2020-1PAWPandLVEDPmaybediscordantConditionsinwhichPAWP>LVEDPMitralstenosisMitralvalveregurgitationLeftatrialmyxomaPulmonaryembolus
ConditionsinwhichPAWP<LVEDPDecreasedLVcomplianceAorticvalveregurgitationHigh(>25mmHg)LVEDP2020-12-0844肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPandLVEDPmaybediscordaSystemicandpulmonaryvascularresistance80*(MPAP-LAP)/肺血流量80*(MAP-RAP)/COR=U/IPVRSVR歐姆定理2020-12-0845肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)SystemicandpulmonaryvasculaSystemicVascularResistanceCausesofSVRVolumeinfusionsHypovolemiaLowCOstatesLVfailureHypothermiaVasopressorsIncreasedbloodviscosityCausesofSVRDiureticsSepsisVasodilatorsPeripheralvasodilationLossofvasomotortone2020-12-0846肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)SystemicVascularResistanceCaPulmonaryVascularResistanceCausesofPVRHypoxiaPEEPPulmonaryedemaPulmonaryhypertensionARDSPulmonaryemboliValvularheartdiseaseCongenitalheartdefectsCausesofPVRVasodilatortherapyProstaglandinsCorrectionofhypoxiaProstacyclin(依前列醇)
2020-12-0847肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PulmonaryVascularResistanceCSvO22020-12-0848肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)SvO22020-12-0848肺動(dòng)脈漂浮導(dǎo)管PAC(新課件ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-0849肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlace2020-12-0850肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0850肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0851肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0851肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0852肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0852肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC為何不能改善預(yù)后?問(wèn)題何在12345不恰當(dāng)?shù)倪m應(yīng)癥PAC相關(guān)的并發(fā)癥數(shù)據(jù)的可靠性不恰當(dāng)?shù)闹委煍?shù)據(jù)解讀的準(zhǔn)確性2020-12-0853肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC為何不能改善預(yù)后?問(wèn)12345不恰當(dāng)?shù)倪m應(yīng)癥PAC相關(guān)WestillneedPAC?2020-12-0854肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WestillneedPAC?2020-12-085到底是誰(shuí)的問(wèn)題?Ibertietal(JAMA1990)美國(guó)和加拿大13家醫(yī)院496MD47%的受試者對(duì)PAC不能作出正確回答GnaegiAetal
(CCM1997)134個(gè)ICU的535MD68%的醫(yī)生所具有的知識(shí)不能滿(mǎn)足PAC使用SquaraP
etal(Chest2002)僅有38%的醫(yī)生按照給出的PAC數(shù)據(jù)選擇了正確的治療方案,但仍有多達(dá)35%的醫(yī)師選擇了錯(cuò)誤的治療方案2020-12-0855肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)到底是誰(shuí)的問(wèn)題?Ibertietal(JAMA199臨床評(píng)價(jià)VS血流動(dòng)力學(xué)103例PAC醫(yī)生在置管前對(duì)血流動(dòng)力學(xué)指標(biāo)的范圍及治療方案進(jìn)行預(yù)測(cè)預(yù)測(cè)準(zhǔn)確性:PAWP30%;COSVRRAP50%留置PAC后:治療計(jì)劃需要重新修正58%
應(yīng)用未預(yù)計(jì)到的治療30%結(jié)論:
1單純根據(jù)臨床評(píng)價(jià)難以準(zhǔn)確預(yù)測(cè)血流動(dòng)力學(xué)指標(biāo)2PAC監(jiān)測(cè)將改變治療策略CritCareMed.1984Jul;12(7):549-53.2020-12-0856肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)臨床評(píng)價(jià)VS血流動(dòng)力學(xué)103例PACCritCareBenefitorHarm?2020-12-0857肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)BenefitorHarm?2020-12-0857肺動(dòng)能否替代PAC?可以替代心輸出量參數(shù)不可替代壓力參數(shù)SCVO2近似替代SVO22020-12-0858肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)能否替代PAC?心輸出量參數(shù)壓力參數(shù)SVO22020-12-ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-0859肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlacePAC要回答的四個(gè)問(wèn)題PAC前負(fù)荷后負(fù)荷心功能氧平衡2020-12-0860肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC要回答的四個(gè)問(wèn)題PAC前負(fù)荷后負(fù)荷心功能氧平衡2020PAC參數(shù)整合:前負(fù)荷CVP(RAP)/PAWP
Anygivenleveloffillingpressure:notreliable!StaticmarkersofcardiacpreloadfailtopredictvolumeresponsivenessFluidchallnge
CVP2-5rulePAWP3-7rule△CO/
△CI/△SV>10%2020-12-0861肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC參數(shù)整合:前負(fù)荷CVP(RAP)/PAWP2020PAC參數(shù)整合:后負(fù)荷左室射血的阻抗及外周阻力SAPMAPSVR后負(fù)荷右室射血的阻抗及外周阻力PAPMPAPPVR2020-12-0862肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC參數(shù)整合:后負(fù)荷左室射血的阻抗及外周阻力后負(fù)荷右室射PAC參數(shù)整合:心臟收縮力CO并不是心臟射血功能的可靠指標(biāo)每搏輸出量(SV)/每搏指數(shù)(SVI)SV/SVI增加的原因:代償;SVR下降SV/SVI降低的原因:前負(fù)荷下降:出血心肌收縮力下降:心功能不全(EF%)后負(fù)荷增加:SVR增加2020-12-0863肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC參數(shù)整合:心臟收縮力CO并不是心臟射血功能的可靠指標(biāo)2PAC參數(shù)整合:氧代謝2020-12-0864肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC參數(shù)整合:氧代謝2020-12-0864肺動(dòng)脈漂浮導(dǎo)管OxygenDelivery:
Whatarethecomponents?OxygenDeliveryDO2CardiacOutputHeartRateStrokeVolumeCaO2PaO2SaO2HbPreloadAfterloadContractilityCVPPCWPPVRSVREF%2020-12-0865肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)OxygenDelivery:
WhatarethePAC目標(biāo)指導(dǎo)性治療ACI>4.5L/min/m2B
DO2>600mL/min/m2C
VO2>170mL/min/m2Shoemaker
WCetal.Chest.1988Dec;94(6):1176-86.2020-12-0866肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC目標(biāo)指導(dǎo)性治療ACI>4.5L/min/m2BPAC目標(biāo)指導(dǎo)性治療CritCareMed.2002Aug;30(8):1686-92CI>4.5L/min/m2DO2>600mL/min/m2VO2>170mL/min/m2PAWP<18mmHg2020-12-0867肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC目標(biāo)指導(dǎo)性治療CritCareMed.2002基于PAC參數(shù)的常見(jiàn)危重病的診斷2020-12-0868肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)基于PAC參數(shù)的常見(jiàn)危重病的診斷2020-12-0868肺動(dòng)基于PAC參數(shù)的急性右心衰診斷前負(fù)荷CVPPAWP正常后負(fù)荷MPAP正常或MAP正?;蛐呐KHRSI氧代謝PaO2/FiO2DO2VO22020-12-0869肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)基于PAC參數(shù)的急性右心衰診斷前負(fù)荷CVPPAWP正常后負(fù)荷基于PAC參數(shù)的急性左心衰診斷前負(fù)荷CVPPAWP后負(fù)荷PVR/SVRMAP正?;蛐呐KHRSI氧代謝PaO2/FiO2DO2VO22020-12-0870肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)基于PAC參數(shù)的急性左心衰診斷前負(fù)荷CVPPAWP后負(fù)荷PV基于PAC參數(shù)的感染性休克診斷前負(fù)荷CVPPAWP后負(fù)荷SVRMAP正?;蛐呐KHRSI氧代謝PaO2/FiO2DO2VO22020-12-0871肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)基于PAC參數(shù)的感染性休克診斷前負(fù)荷CVPPAWP后負(fù)荷SV基于PAC參數(shù)的失血性休克診斷前負(fù)荷CVPPAWP后負(fù)荷SVRMAP正?;蛐呐KHRSI氧代謝PaO2/FiO2DO2正?;騐O22020-12-0872肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)基于PAC參數(shù)的失血性休克診斷前負(fù)荷CVPPAWP后負(fù)荷SV基于PAC參數(shù)的急性肺栓塞診斷前負(fù)荷CVPPAWP后負(fù)荷MPAPMAP正常或心臟HRSI氧代謝PaO2/FiO2DO2VO22020-12-0873肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)基于PAC參數(shù)的急性肺栓塞診斷前負(fù)荷CVPPAWP后負(fù)荷MPPAC病例2020-12-0874肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC病例2020-12-0874肺動(dòng)脈漂浮導(dǎo)管PAC(新課Case1Fluidchallenge2020-12-0875肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case1Fluidchallenge2020-Case2Fluidchallenge2020-12-0876肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case2Fluidchallenge2020-Case2Diuretic2020-12-0877肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case2Diuretic2020-12-0877肺Case2Diuretic2020-12-0878肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case2Diuretic2020-12-0878肺動(dòng)Case3VasodilatorTherapy71/MAnteriorwallmyocardialinfarctionPE:BP132/82HR116R28.+2edemaofthelowerextremitiesLab:Na132Scr88ECG:anteriorleadS-TelevationsCRX:cardiomegalywithpulmonaryedemaThepatientwasadmittedtotheICUandPACwasplacedforoptimizationofcardiacstatusNitroprussidewastitrated2020-12-0879肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case3VasodilatorTherapy71/Case3VasodilatorTherapy2020-12-0880肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case3VasodilatorTherapy202Case4Cardiactonic2020-12-0881肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case4Cardiactonic2020-12-Case4Cardiactonic2020-12-0882肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case4Cardiactonic2020-12-08Case5SepticShock52/FESWL;urinarytractinfectionsBP100/45HR120RR40T39WBC13100,Na138,K5.1,Glu16,
scr180CRX:normal;EKG:sinustachycardia.UrineCultures;startedonmezlocillinandgentamicin.Onday2,SBPdroppedto70mmHg;ABG(Fi0260%):pH7.38,PaO242,PaCO249Sa0275%.CRXshoweddiffusebilateralinfiltrates.TransferredtotheICU:volumeresuscitated,intubatedandstartedonintravenousinotropesandvasopressors.PACwasinserted.Thepatientremainedoliguric,uremicandthereforehemodialysiswasstarted.MVwasmaintainedwithhighFiO2andPEEP2020-12-0883肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case5SepticShock52/F2020-Case5SepticShock2020-12-0884肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Case5SepticShock2020-12-0Dr.Feng2020-12-0885肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Dr.Feng2020-12-0885肺動(dòng)脈漂浮導(dǎo)管PAC(謝謝感謝您的聆聽(tīng)
您的關(guān)注使我們更努力此課件下載后可自行編輯修改關(guān)注我每天分享干貨2020-12-0886肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)謝謝感謝您的聆聽(tīng)
您的關(guān)注使我們更努力此課件下載后可自行編輯Dr.Feng肺動(dòng)脈漂浮導(dǎo)管PAC2020-12-0887肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Dr.Feng肺動(dòng)脈漂浮導(dǎo)管PAC2020-12-081肺動(dòng)ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-0888肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlaceWhatisPulmonaryArteryCatheter?Fullname:Swan-GanzCatheterUsedittomonitorapatient’shemodynamicswhenwecantanswerthequestionusingnoninvasive/clinicalmeasures
2020-12-0889肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatisPulmonaryArteryClinicaluseofthePAC(Diagnosis)Differentiationamongcausesofshock
CardiogenicHypovolemicDistributive(sepsis)Obstructive(massivepulmonaryembolism)
DifferentiationofpulmonaryedemaCardiogenicNoncardiogenic
EvaluationofpulmonaryhypertensionDiagnosisofleft-to-rightintracardiacshuntDiagnosisofpericardialtamponade2020-12-0890肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ClinicaluseofthePAC(DiagnClinicaluseofthePAC(Therapy)ManagementofperioperativepatientwithunstablecardiacstatusManagementofcomplicatedmyocardialinfarctionManagementofseverepreeclampsiaGuidetopharmacologictherapy
Vasopressors;Inotropes;VasodilatorsGuidetononpharmacologictherapy
Fluidmanagement;Burns;Renalfailure;Sepsis;Heartfailure;DecompensatedcirrhosisVentilatormanagement
AssessmentofbestPEEPforDO22020-12-0891肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ClinicaluseofthePAC(TherapContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-0892肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlaceStructureofPAC2020-12-0893肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)StructureofPAC2020-12-087肺動(dòng)脈PAC2020-12-0894肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC2020-12-088肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)首選:右頸內(nèi)靜脈2020-12-0895肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)首選:右頸內(nèi)靜脈2020-12-089肺動(dòng)脈漂浮導(dǎo)管PAC(ComparisonamongPAcatheterinsertionsites2020-12-0896肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ComparisonamongPAcatheteriPACinsertionRightinternaljugularvein
ShortestandstraightestpathtotheheartLeftsubclavianDoesnotrequirethePACtopassandcourseatanacuteangletoentertheSVCFemoralveinsDistantsitesPassingaPACintotheheartcanbedifficultFluoroscopicassistancemaybenecessaryCompressibleandpreferableiftheriskofhemorrhageishigh2020-12-0897肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PACinsertionRightinternaljPACinsertionAfterinsertingthePACasfarasthe20cmmark,theballoonisinflatedwithair.Inflationshouldbeslowandcontrolled(1mL/s)andshouldnotsurpasstherecommendedvolume(1.5mL).AlwaysinflatetheballoonbeforeadvancingthePACandalwaysdeflatetheballoonbeforewithdrawingthePAC.
CRX:checkthepositionofthePACPAdiastolicpressure~PAWP2020-12-0898肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PACinsertionAfterinsertingtPAConCRX(PA)2020-12-0899肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAConCRX(PA)2020-12-0813肺動(dòng)脈漂Placementofthecatheter
2020-12-08100肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Placementofthecatheter
2020RightAtrium>>20cmNormalrightatrialpresssureis0-6cmHg.Normaloxygencontent15%(ml/dL)NormalO2saturation75%2020-12-08101肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RightAtrium>>20cm2020-12-081WaveformsofCVP
2020-12-08102肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WaveformsofCVP
2020-12-081EKG-RAPEKG
MechanicaleventRAP80–100millisecondsafterPwaveRAsystole
a
waveRAdiastolex
descentAfterQRSTricuspidvalveclosurecwaveAfterpeakofTwaveRAfilling/tricuspidvalveclosedv
waveRAemptyingatopeningoftricuspidvalve/onsetofrightventriclediastole
y
descent2020-12-08103肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)EKG-RAPEKGMechanicaleventRightAtrium2020-12-08104肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RightAtrium2020-12-0818肺動(dòng)脈漂浮導(dǎo)RightventricularwaveformRVsystolic=17-30cmHgRVdiastolic=0-6cmHgRVO2content=15%(ml/dL)RVO2saturation75%2020-12-08105肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RightventricularwaveforPulmonaryarterywaveform
NormalPApressure,systolic15-30NormalPApressure,diastolic5-13O2content15%(ml/dL)O2saturation75%2020-12-08106肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PulmonaryarterywaveforEKG-PAPEKGMechanicaleventPAPTwaveRightventricleejectionofbloodintopulmonaryvasculature
Systolic
PAS15–30mmHg80millisecondsafteronsetofQRS
IndirectindicatorofLVEDP
End-diastolic
(PAEDP8–12mmHg)Mean(9–18mmHg)PAS:pulmonaryarterysystolicLVEDP:leftventricularend-diastolicpressurePAEDP:pulmonaryarteryend-diastolicpressure2020-12-08107肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)EKG-PAPEKGMechanicaleventPulmonaryarterywaveform
2020-12-08108肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)Pulmonaryarterywaveform
2020PAWPwaveform2020-12-08109肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPwaveform2020-12-0823肺動(dòng)脈PAWPwaveform2020-12-08110肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPwaveform2020-12-0824肺動(dòng)脈漂浮EKG-PAWPEKG
MechanicaleventPAWPAlignedwiththeendoftheQRS
Leftatrial(LA)systolea
waveLAdiastolex
descentT-PintervalLAfilling/mitralvalveclosedv
waveLAemptyingatopeningofmitralvalve/onsetofleftventriclediastoley
descent2020-12-08111肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)EKG-PAWPEKGMechanicaleventPAWPwaveform2020-12-08112肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPwaveform2020-12-0826肺動(dòng)脈漂浮ECG--CVP--PAWP2020-12-08113肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ECG--CVP--PAWP2020-12-0827HowdouknowurinZone3?CathetershouldbebelowtheleftatriumonCRXIfthereismarkedrespiratoryvairationinthePAWPtracingyouarelikelynotinZone3IfPAD>PAWPthenyouarelikelynotinZone32020-12-08114肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)HowdouknowurinZone3?CRapidFlushTest(方波試驗(yàn))2020-12-08115肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)RapidFlushTest(方波試驗(yàn))2020-12-PhlebostaticAxis2020-12-08116肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PhlebostaticAxis2020-12-08PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-08117肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-0831肺PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-08118肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC并發(fā)癥、可能原因、預(yù)防及處理2020-12-0832肺ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
Parameterintegration2020-12-08119肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlaceHemodynamicvaluesofnormaladults2020-12-08120肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)HemodynamicvaluesofnormHemodynamicMonitoringCOCISVSVIRAP(CVP)PAPPAWPCardiacoutputPressureSvO22020-12-08121肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)HemodynamicMonitoringRAP(CVP)CardiacOutput(CO)定義:在1min內(nèi)從心室射出的血液總量公式:CO=HRxSVCO=4~8L/min2020-12-08122肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)CardiacOutput(CO)CardiacOutputIndex(CI)
CI=CO/BSA正常值:2.8–4.2L/min/m2CI更能體現(xiàn)患者的個(gè)體差異性2020-12-08123肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)CardiacOutputIndex(CI)CI每搏量(SV)
與每搏量指數(shù)(SVI)SV定義:每次心跳所射出的血液量SV=CO/HRSV正常值:50-110ml/beatSVI=SV/BSASVI正常值:30-65ml/m2/beat2020-12-08124肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)每搏量(SV)與每搏量指數(shù)(SVI)SV定義:每次心跳WhatElevatestheRightAtrialPressure?RVinfarctPulmonaryhypertensionPulmonarystenosisLefttorightshuntTricuspidvalvulardiseaseLeftheartfailure2020-12-08125肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatElevatestheRightAtrialProminentRApulsationsProminentawave:
TricuspidstenosisCannonawave:
AVdissociation
VentriculartachycardiaProminentvwave:
TricuspidregurgitationorVSD2020-12-08126肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ProminentRApulsationsPromineWhatIncreasesRVPressures?RVfailurePulmonaryhypertensionPulmonarystenosisPulmonaryEmbolismCardiomyopathyCardiactamponadeCardiacconstriction2020-12-08127肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatIncreasesRVPressures?RVWhatElevatesPApressure?VolumeOverload(backflow)PrimarylungdiseasePrimarypulmonaryhypertensionPulmonaryEmbolismLefttorightshuntMitralValveDisease2020-12-08128肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WhatElevatesPApressure?Volu用壓力推測(cè)心室舒張末期容量的前提
導(dǎo)管位置無(wú)二尖瓣心室順應(yīng)性正確疾病正常
PAWP~LAP~LVEDP~LVEDV~Preload2020-12-08129肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)用壓力推測(cè)心室舒張末期容量的前提2020-1PAWPandLVEDPmaybediscordantConditionsinwhichPAWP>LVEDPMitralstenosisMitralvalveregurgitationLeftatrialmyxomaPulmonaryembolus
ConditionsinwhichPAWP<LVEDPDecreasedLVcomplianceAorticvalveregurgitationHigh(>25mmHg)LVEDP2020-12-08130肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAWPandLVEDPmaybediscordaSystemicandpulmonaryvascularresistance80*(MPAP-LAP)/肺血流量80*(MAP-RAP)/COR=U/IPVRSVR歐姆定理2020-12-08131肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)SystemicandpulmonaryvasculaSystemicVascularResistanceCausesofSVRVolumeinfusionsHypovolemiaLowCOstatesLVfailureHypothermiaVasopressorsIncreasedbloodviscosityCausesofSVRDiureticsSepsisVasodilatorsPeripheralvasodilationLossofvasomotortone2020-12-08132肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)SystemicVascularResistanceCaPulmonaryVascularResistanceCausesofPVRHypoxiaPEEPPulmonaryedemaPulmonaryhypertensionARDSPulmonaryemboliValvularheartdiseaseCongenitalheartdefectsCausesofPVRVasodilatortherapyProstaglandinsCorrectionofhypoxiaProstacyclin(依前列醇)
2020-12-08133肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PulmonaryVascularResistanceCSvO22020-12-08134肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)SvO22020-12-0848肺動(dòng)脈漂浮導(dǎo)管PAC(新課件ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-08135肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlace2020-12-08136肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0850肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-08137肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0851肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-08138肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)2020-12-0852肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC為何不能改善預(yù)后?問(wèn)題何在12345不恰當(dāng)?shù)倪m應(yīng)癥PAC相關(guān)的并發(fā)癥數(shù)據(jù)的可靠性不恰當(dāng)?shù)闹委煍?shù)據(jù)解讀的準(zhǔn)確性2020-12-08139肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC為何不能改善預(yù)后?問(wèn)12345不恰當(dāng)?shù)倪m應(yīng)癥PAC相關(guān)WestillneedPAC?2020-12-08140肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)WestillneedPAC?2020-12-085到底是誰(shuí)的問(wèn)題?Ibertietal(JAMA1990)美國(guó)和加拿大13家醫(yī)院496MD47%的受試者對(duì)PAC不能作出正確回答GnaegiAetal
(CCM1997)134個(gè)ICU的535MD68%的醫(yī)生所具有的知識(shí)不能滿(mǎn)足PAC使用SquaraP
etal(Chest2002)僅有38%的醫(yī)生按照給出的PAC數(shù)據(jù)選擇了正確的治療方案,但仍有多達(dá)35%的醫(yī)師選擇了錯(cuò)誤的治療方案2020-12-08141肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)到底是誰(shuí)的問(wèn)題?Ibertietal(JAMA199臨床評(píng)價(jià)VS血流動(dòng)力學(xué)103例PAC醫(yī)生在置管前對(duì)血流動(dòng)力學(xué)指標(biāo)的范圍及治療方案進(jìn)行預(yù)測(cè)預(yù)測(cè)準(zhǔn)確性:PAWP30%;COSVRRAP50%留置PAC后:治療計(jì)劃需要重新修正58%
應(yīng)用未預(yù)計(jì)到的治療30%結(jié)論:
1單純根據(jù)臨床評(píng)價(jià)難以準(zhǔn)確預(yù)測(cè)血流動(dòng)力學(xué)指標(biāo)2PAC監(jiān)測(cè)將改變治療策略CritCareMed.1984Jul;12(7):549-53.2020-12-08142肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)臨床評(píng)價(jià)VS血流動(dòng)力學(xué)103例PACCritCareBenefitorHarm?2020-12-08143肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)BenefitorHarm?2020-12-0857肺動(dòng)能否替代PAC?可以替代心輸出量參數(shù)不可替代壓力參數(shù)SCVO2近似替代SVO22020-12-08144肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)能否替代PAC?心輸出量參數(shù)壓力參數(shù)SVO22020-12-ContentsIntroductionPACPlacement
HemodynamicMonitoringControversyonPAC
ParameterintegrationCasesDiscussion2020-12-08145肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)ContentsIntroductionPACPlacePAC要回答的四個(gè)問(wèn)題PAC前負(fù)荷后負(fù)荷心功能氧平衡2020-12-08146肺動(dòng)脈漂浮導(dǎo)管PAC(新課件)PAC要回答的四個(gè)問(wèn)題PAC前負(fù)荷后負(fù)荷心功能氧平衡2020PAC參數(shù)整合:前負(fù)荷CVP(RAP)/PAWP
Anygivenleveloffillingpressure:notreliable!StaticmarkersofcardiacpreloadfailtopredictvolumeresponsivenessFluid
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二五年度代理注銷(xiāo)公司及客戶(hù)資源保護(hù)合同
- 二零二五年度互聯(lián)網(wǎng)+農(nóng)業(yè)股東合作協(xié)議范本
- 2025版預(yù)制構(gòu)件生產(chǎn)與施工合同
- 二零二五年度廚房設(shè)備銷(xiāo)售合同及廚電智能化升級(jí)服務(wù)協(xié)議
- 2025年版綠色能源股份代持合同(可持續(xù)能源)
- 2025版全球化工品運(yùn)輸合同
- 二零二五年度建筑節(jié)能工程項(xiàng)目管理承包合同
- 2025年度餐飲連鎖經(jīng)營(yíng)合作合同書(shū)
- 二零二五年度房屋租賃合同違約責(zé)任書(shū)
- 2025版海外航空行業(yè)員工外派服務(wù)合同
- 提升高價(jià)值專(zhuān)利培育培訓(xùn)
- 醫(yī)院健康教育內(nèi)容及方式
- 浙江臺(tái)州市2024-2025學(xué)年高二下學(xué)期6月期末數(shù)學(xué)(含答案)
- 業(yè)務(wù)人員財(cái)務(wù)培訓(xùn)
- 4m1e基礎(chǔ)知識(shí)培訓(xùn)
- DB53∕T 1284-2024 柔性懸索橋設(shè)計(jì)細(xì)則
- 巖溶區(qū)路基注漿密實(shí)度檢測(cè)
- 2025年數(shù)據(jù)分析師面試試題及答案
- 考試點(diǎn)相關(guān)管理制度
- 2025版《汽車(chē)維修店事故隱患內(nèi)部報(bào)告獎(jiǎng)勵(lì)制度》(修訂版)
- 2023年4月黑龍江省考公務(wù)員結(jié)構(gòu)化面試真題試題試卷答案解析
評(píng)論
0/150
提交評(píng)論